+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Plant Extracts in Neurodegenerative Diseases

  • Book

  • June 2022
  • Elsevier Science and Technology
  • ID: 5548583

Plant Extracts in Neurodegenerative Disease examines the therapeutic efficacy of plant extracts and the lead compounds contained therein that can significantly improve symptoms of diseases of the brain. Providing insights into the protective mechanisms of these bioactive plant compounds to treat Alzheimer's Disease, Parkinson's Disease, motor neuron disease, and other neurodegenerative diseases, the book also discusses the pros and cons of using these types of treatments, along with perspectives to overcome current challenges. With chapters looking at individual diseases, readers will learn about studies unique to each condition, including Huntington's Disease, spinocerebellar ataxia, SMA, ALS and prion disease.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Introduction 2. Plant Extracts in the Treatment of Alzheimer's Disease 3. Plant Extracts in the Treatment of Parkinson's Disease 4. Plant Extracts in the Treatment of Prion Disease 5. Neuroprotective Role in Motor Neuron Diseases 6. Plant Extracts Ameliorate Huntington's Disease Symptoms 7. Phytochemicals and Their Potential Protective Effects Against Spinocerebellar Ataxia 8. Efficacy of Various Plant Compounds in the Treatment of Spinal Muscular Atrophy 9. Improvement of ALS Symptoms Using Plant Extracts 10. Neuroprotective Role of Curcumin in ALS

Authors

Magisetty Obulesu Regional Agricultural Research Station, Acharya N.G. Ranga Agricultural University, Tirupati, India. Magisetty Obulesu is a research associate at the Regional Agricultural Research Station, Acharya N.G. Ranga Agricultural University, Tirupati, India. He has 20 years of research and teaching experience. He is also an editorial board of nanotechnology journals including SciFed Nanotech Research Letters, SciFed Drug Delivery Research, Current Updates in Nanotechnology and Journal of Nanotechnology and Materials Science. His research areas include food science, pathology of neurodegenerative diseases such as Alzheimer's disease, designing polymer-based biomaterials such as hydrogels, and development of metal chelators to overcome metal induced toxicity. He has researched Alzheimer's disease and developed an aluminium-induced neurotoxicity rabbit model. Mr. Obulesu's present research focuses on development of redox-active injectable hydrogels of polyion complex. He has written three books and edited two more; he is also the first and corresponding author for majority of his articles.